Wolfe Research Upgrades Elevance Health to Outperform, Announces $425 Price Target

Benzinga · 2d ago
Wolfe Research analyst Justin Lake upgrades Elevance Health (NYSE:ELV) from Peer Perform to Outperform and announces $425 price target.